Can lorlatinib/lorlatinib be taken long-term?

Lorlatinib/Lorlatinib (Lorlatinib) is a targeted therapy drug mainly used to treat ALK-positive non-small cell lung cancer (NSCLC). The drug blocks the growth and spread of tumor cells by inhibiting the abnormal protein produced by mutations in the ALK gene. Lorlatinib is well tolerated and has relatively mild side effects compared to traditional chemotherapy drugs. Common adverse reactions include fatigue, weight gain, hyperlipidemia, etc. These side effects can often be managed with monitoring and appropriate medication adjustments, and many patients are able to maintain a relatively good quality of life while using them.

The efficacy of lorlatinib has been outstanding in multiple clinical trials, especially in ALK-positive patients. Its objective response rate and progression-free survival (PFS) have obvious advantages over other ALK inhibitors. Therefore, for those patients who achieve a positive response to short-term treatment, doctors often recommend continued use of lorlatinib to prolong disease control.

However, long-term use of lorlatinib is not without its challenges. Over time, patients may develop drug resistance, requiring doctors to continually evaluate treatment effectiveness and adjust treatment regimens if necessary. Some studies have shown that long-term use of lorlatinib may lead to the emergence of drug-resistant mutations, thereby affecting the effectiveness of the drug. Therefore, regular imaging examinations and biomarker testing are very important to detect drug resistance in a timely manner.

Long-term use of lorlatinib may cause some cumulative side effects. For example, persistently high cholesterol levels may lead to increased cardiovascular risk, requiring close collaboration with your doctor to develop a healthy diet to manage this problem. In addition, during long-term medication, patients should regularly monitor liver function, kidney function, blood routine and other related indicators to ensure the normal operation of various body functions.